Robot Rally: Unleashing Profit Potential in NVAX and Beyond (+4% in a Week!).
On the American stock market, we are currently witnessing an excellent trend, with new highs being set almost every day. Our robots, including the ones mentioned below, have capitalized on this momentum, earning over 4% in just the past week. These robots can be found at the following links:
- Day Trader - Medium Volatility Stocks for Active Trading (TA/FA)
- Day Trader - High Volatility Stocks for Active Trading (TA/FA)
- Swing Trader - Volatility Balanced Strategy (TA)
These robots are particularly suitable for traders who prefer a balanced strategy. The Day Trader robots focus on stocks with medium and high volatility, allowing traders to adapt their trading algorithms based on market activity.
Here's how these robots operate:
Step 1: The algorithms evaluate the short- and medium-term trends for each stock. Step 2: Using a proprietary set of technical indicators, the robots identify signals to open trades. Step 3: Based on the volatility and direction of the trends, separate algorithms determine the position size for each trade.
Once a trade is initiated, the AI robots set a "Take Profit" order, with the distance determined by the current market volatility. To exit a position, the robots utilize a 3% stop loss of the opening price and a flexible trailing stop, which helps preserve profits in case of a market reversal.
Please note that the robot's trading results are displayed without the use of margin. For comprehensive trading statistics and an equity chart, you can click on the "Show More" button on the robot's page. The "Open Trades" tab allows you to observe how the AI robot selects and executes trades in real-time, while the "Closed Trades" tab provides a record of all past trades conducted by the robot.
Join us as we explore the exciting world of automated trading and uncover the potential of NVAX and other stocks in this exhilarating market surge.
NVAX's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for NVAX turned positive on November 21, 2024. Looking at past instances where NVAX's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NVAX advanced for three days, in of 274 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 157 cases where NVAX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on December 20, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on NVAX as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The 50-day moving average for NVAX moved below the 200-day moving average on December 04, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NVAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.292). P/E Ratio (0.000) is within average values for comparable stocks, (87.498). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.756). NVAX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (1.437) is also within normal values, averaging (260.038).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a company which engages in development of novel recombinant vaccines
Industry Biotechnology